CD44 and breast neoplasm: Indeed, in this study we demonstrate that the combined TME Stimulation by estrogen+TNFα+EGF has enriched Luminal-A breast tumor cells not only for the CD44+/β1+ sub-population, but also for the CD44+/CD24low/− sub-population.